We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.12B
1-Year Est. Return 144%
This Fund
S&P 500
This Quarter Est. Return
+39.07%
1 Year Est. Return
+144%
3 Year Est. Return
+348.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.58B
AUM Growth
+$465M
Cap. Flow
-$336M
Cap. Flow %
-9.38%
Top 10 Hldgs %
52.59%
Holding
77
New
11
Increased
13
Reduced
21
Closed
21

Top Buys

Rank Stock Value
1
TARS icon
Tarsus Pharmaceuticals
TARS
+$61.5M
2
LBRX
LB Pharmaceuticals
LBRX
+$53.2M
3
EXAS
Exact Sciences
EXAS
+$50M
4
AKRO
Akero Therapeutics
AKRO
+$46.4M
5
PCVX icon
Vaxcyte
PCVX
+$28.2M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$176M
2
PTGX icon
Protagonist Therapeutics
PTGX
+$87M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$52.9M
4
RARE icon
Ultragenyx Pharmaceutical
RARE
+$49.1M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$41.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEPN
76
Septerna Inc
SEPN
$1.54B
– –
-121,716
Closed -$1.29M
MTSR
77
DELISTED
Metsera Inc
MTSR
– –
-1,094,408
Closed -$31.1M
1 2 3
4

Similar funds

AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Deep Track Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Deep Track Capital held 77 positions worth $3.58B, up 15% from $3.12B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Deep Track Capital withdrew a net $336M in Q3 2025, closing 21 positions and reducing 21 holdings. Its most notable exit was Insmed, an estimated $176M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

Against the trend, Deep Track Capital opened a new position in LB Pharmaceuticals worth $52.9M.

  • Deep Track Capital's largest Q3 2025 buy was LB Pharmaceuticals: 3,352,804 shares worth $52.9M.
  • Deep Track Capital added most to Tarsus Pharmaceuticals in Q3 2025, an estimated $61.5M increase.
  • Deep Track Capital's biggest Q3 2025 reduction was Protagonist Therapeutics, cutting an estimated $87M.
  • Deep Track Capital fully exited Insmed in Q3 2025, selling an estimated $176M.
  • Deep Track Capital's ten largest holdings make up 53% of its $3.58B portfolio in Q3 2025.
  • Deep Track Capital opened 11 new positions and closed 21 in Q3 2025.
  • Deep Track Capital's portfolio value rose 15% quarter-over-quarter to $3.58B.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.